Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.
Erika P. Hamilton, MD
Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator
Dr. Hamilton joined Sarah Cannon in 2013. Dr. Hamilton cares for patients with breast and gynecologic cancer. As the director of the breast cancer and gynecologic cancer research program, she oversees the program and the clinical trial menu for these cancers across the Sarah Cannon network.
After receiving an undergraduate degree from Washington and Lee University in Virginia, Dr. Hamilton completed her medical degree and residency from University of North Carolina in Chapel Hill. She received her fellowship training in hematology and oncology from Duke University in Durham, North Carolina, where she was recognized as a Top 5 Finalist for Duke's Annual House staff Fellow Teaching Award. She is board certified in internal medicine and oncology. Additionally, she is a partner with Tennessee Oncology, PLLC.